Ultrahigh molecular weight polyethylene particles have direct effects on proliferation, differentiation, and local factor production of MG63 osteoblast-like cells

Journal of Orthopaedic Research

Volumn 17, Issue 1, 1999, Pages 9-17

  Dean, D D ^a   Schwartz, Z ^a   Blanchard, C R ^a   Liu, Y ^a   Agrawal, C M ^a   Lohmann, C H ^a   Sylvia, V L ^a   Boyan, B D ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; ORTHOPEDICS; PARTICLES (PARTICULATE MATTER); PROSTHETICS; TISSUE CULTURE; ULTRAHIGH MOLECULAR WEIGHT POLYETHYLENES; WEAR OF MATERIALS;

CELL DIFFERENTIATION; CELL PROLIFERATION; LOCAL FACTOR PRODUCTION; OSTEOBLAST CELLS;

BIOMATERIALS;

OSTEOCALCIN; POLYETHYLENE; PROSTAGLANDIN E2;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; ENDOPROSTHESIS LOOSENING; FOREIGN BODY GRANULOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; OSTEOBLAST; OSTEOLYSIS; PATHOPHYSIOLOGY; POLITEF IMPLANT; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; STRESS STRAIN RELATIONSHIP;

EID: 0033048053     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.1100170104     Document Type: Article

References (53)

1. 1 Athanasou NA: Cellular biology of bone‐resorbing cells. J Bone Joint Surg [Am] 78: 1096–1112, 1996
2. 2 Bonewald LF, Mundy GR: Role of transforming growth factorbeta in bone remodeling. Clin Orthop 250: 261–276, 1990
3. 3 Bonewald LF, Schwartz Z, Swain LD, Ramirez V, Poser J, Boyan BD: Stimulation of plasma membrane and matrix vesicle enzyme activity by transforming growth factor‐β in osteosarcoma cell cultures. J Cell Physiol 145: 200–206, 1990
4. 4 Bonewald LF, Schwartz Z, Swain LD, Boyan BD: Stimulation of matrix vesicle enzyme activity in osteoblast‐like cells by 1,25 (OH) 2 D 3 and transforming growth factor beta (TGF beta). Bone Miner 17: 139–144, 1992
5. 5 Boyan BD, Schwartz Z, Swain LD, Carnes DL Jr, Zislis T: Differential expression of phenotype by resting zone and growth region costochondral chondrocytes in vitro. Bone 9: 185–194, 1988
6. 6 Boyan BD, Schwartz Z, Bonewald LF, Swain LD: Localization of 1,25‐(OH) 2 D 3 ‐responsive alkaline phosphatase in osteoblast‐like cells (ROS 17/2.8, MG 63, and MC 3T3) and growth cartilage cells in culture. J Biol Chem 264: 11879–11886, 1989
7. 7 Braun G, Kohavi D, Amir D, Luna M, Caloss R, Sela J, Dean DD, Boyan BD, Schwartz Z: Markers of primary mineralization are correlated with bone‐bonding ability of titanium or stainless steel in vivo. Clin Oral Implants Res 6: 1–13, 1995
8. 8 Bretaudiere JP, Spillman T: Alkaline phosphatases. In: Methods of Enzymatic Analysis, vol 4, pp 75–92. Ed by HU Bergmeyer, J Bergmeyer, and M. Grassl weinheim, Verlag Chemie, 1983
9. 9 Campbell P, Ma S, Yeom B, McKellop H, Schmalzried TP, Amstutz HC: Isolation of predominantly submicron‐sized UHMWPE wear particles from periprosthetic tissues. J Biomed Mater Res 29: 127–131, 1995
10. 10 Centrella M, McCarthy TL, Canalis E: Glucocorticoid control of transforming growth factor β (TGFβ) binding and effects in osteoblast‐enriched cultures from fetal rat bone [abstract]. J Bone Miner Res 5: S211, 1990
11. 11 Charnley J: Tissue reactions to implanted plastics. In: Acrylic Cement in Orthopaedic Surgery, pp 1–9. Ed by J Charnley Baltimore, Williams and Wilkins, 1970
12. 12 Chyun YS, Raisz LG: Stimulation of bone formation by prostaglandin E 2. Prostaglandins 27: 97–103, 1984
13. 13 Dallas SL, Park‐Snyder S, Miyazono K, Twardzik D, Mundy GR, Bonewald LF: Characterization and autoregulation of latent transforming growth factor β (TGFβ) complexes in osteoblast‐like cell lines: production of a latent complex lacking the latent TGF beta‐binding protein. J Biol Chem 269: 6815–6821, 1994
14. 14 Dziak RM: Prostaglandins as mediators of bone cell metabolism. In: Calcium in Biological Systems, pp 533–539. Ed by RP Rubin GB Weiss and JW Putney New York, Plenum Publishing, 1985
15. 15 Franceschi RT, James WM, Zerlauth G: 1α,25‐dihydroxyvitamin D 3 specific regulation of growth, morphology, and fibronectin in a human osteosarcoma cell line. J Cell Physiol 123: 401–409, 1985
16. 16 Franceschi RT, Romano PR, Park KY: Regulation of type I collagen synthesis by 1,25‐dihydroxyvitamin D 3 in human osteosarcoma cells. J Biol Chem 263: 18938–18945, 1988
17. 17 Gerstenfeld LC, Chipman SD, Glowacki J, Lian JB: Expression of differentiated function by mineralizing cultures of chicken osteoblasts. Dev Biol 122: 49–60, 1987
18. 18 Glant TT, Jacobs JJ, Molnar G, Shanbhag AS, Valyon M, Galante JO: Bone resorption activity of particulate‐stimulated macrophages. J Bone Miner Res 8: 1071–1079, 1993
19. 19 Glant TT, Jacobs JJ, Mikecz K, Yao J, Chubinskaja S, Williams JM, Urban RL, Shanbhag AS, Lee S, Sumner DR: Particulate‐induced, prostaglandin‐ and cytokine‐mediated bone resorption in an experimental system and in failed joint replacements. Am J Ther 3: 27–41, 1996
20. 20 Goodman S, Aspenberg P, Song Y, Regula D, Lidgren L: Polyethylene and titanium alloy particles reduce bone formation: dose‐dependence in bone harvest chamber experiments in rabbits. Acta Orthop Scand 67: 599–605, 1996
21. 21 Hale LV, Kemick ML, Wuthier RE: Effect of vitamin D metabolites on the expression of alkaline phosphatase activity by epiphyseal hypertrophic chondrocytes in primary cell culture. J Bone Miner Res 1: 489–495, 1986
22. 22 Harmand MF: In vitro study of biodegradation of a Co‐Cr alloy using a human cell culture model. J Biomater Sci Polym Ed 6: 809–814, 1995
23. 23 Horowitz SM, Gonzales JB: Inflammatory response to implant particulates in a macrophage/osteoblast coculture model. Calcif Tissue Int 59: 392–396, 1996
24. 24 Hukkanen M, Corbett SA, Batten J, Konttinen YT, McCarthy ID, Maclouf J, Santavirta S, Hughes SP, Polak JM: Aseptic loosening of total hip replacement: macrophage expression of inducible nitric oxide synthase and cyclo‐oxygenase‐2, together with peroxynitrite formation, as a possible mechanism for early prosthesis failure. J Bone Joint Surg [Br] 79: 467–474, 1997
25. 25 Ibaraki B, Termine JD, Whitson SW, Young MF: Bone matrix mRNA expression in differentiating fetal bovine osteoblasts. J Bone Miner Res 7: 743–754, 1992
26. 26 Igarashi K, Hirafuji M, Adachi H, Shinoda H, Mitani H: Role of endogenous PGE 2 in osteoblastic functions of a clonal osteoblast‐like cell, MC3T3‐E1. Prostaglandins Leuk Essen Fatty Acids 50: 169–172, 1994
27. 27 Jukkola A, Risteli L, Melkko J, Risteli J: Procollagen synthesis and extracellular matrix deposition in MG‐63 osteosarcoma cells. J Bone Miner Res 8: 651–657, 1993
28. 28 Kieswetter K, Schwartz Z, Hummert TW, Cochran DL, Simpson J, Dean DD, Boyan BD: Surface roughness modulates the local production of growth factors and cytokines by osteoblast‐like MG‐63 cells. J Biomed Mater Res 32: 55–63, 1996
29. 29 Landry ME, Jaroszewski DE, Szygenda M, Mabrey JD, Blanchard C, Agrawal CM: Numerical analysis of individual UHMWPE particles. [abstract]. Trans Fifth World Biomat Congress, 1: 283, 1996
30. 30 Lian JB, Stein GS: The developmental stages of osteoblast growth and differentiation exhibit selective responses of genes to growth factors (TGFβ1) and hormones (vitamin D and glucocorticoids). J Oral Implantol 19: 95–105, 1993
31. 31 Lowry OH, Rosebrough NJ, Farr AL, Rano RI: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275, 1951
32. 32 Maloney WJ, Smith RL, Schmalzried TP, Chiba J, Huene D, Rubash H: Isolation and characterization of wear particles generated in patients who have had failure of a hip arthroplasty without cement. J Bone Joint Surg [Am] 77: 1301–1310, 1995
33. 33 Marshall TS, Schwartz Z, Swain LD, Amir D, Sela J, Gross U, Mueller‐Mai C, Boyan BD: Matrix vesicle enzyme activity in endosteal bone following implantation of bonding and nonbonding implant materials. Clin Oral Implants Res 2: 112–120, 1991
34. 34 Martin JY, Schwartz Z, Hummert TW, Schraub DM, Simpson J, Lankford J, Dean DD, Cochran DL, Boyan BD: Effect of titanium surface roughness on proliferation, differentiation, and protein synthesis of human osteoblast‐like cells (MG63). J Biomed Mater Res 29: 389–401, 1995
35. 35 McKellop HA, Campbell P, Park SH, Schmalzried TP, Grigoris P, Amstutz HC, Sarmiento A: The origin of submicron polyethylene wear debris in total hip arthroplasty. Clin Orthop 311: 3–20, 1995
36. 36 Nefussi JR, Baron R: PGE 2 stimulates both resorption and formation of bone in vitro: differential responses of the periosteum and the endosteum in fetal rat long bone cultures. Anat Rec 211: 9–16, 1985
37. 37 O'Keefe RJ, Puzas JE, Brand JS, Rosier RN: Effects of transforming growth factor‐beta on matrix synthesis by chick growth plate chondrocytes. Endocrinology 122: 2953–2961, 1988
38. 38 Pandey R, Quinn J, Joyner C, Murray DW, Triffitt JT, Athanasou NA: Arthroplasty implant biomaterial particle associated macrophages differentiate into lacunar bone resorbing cells. Ann Rheum Dis 55: 388–395, 1996
39. 39 Quinn JM, Matsumara Y, Tarin D, McGee JO, Athanasou NA: Cellular and hormonal mechanisms associated with malignant bone resorption. Lab Invest 71: 465–471, 1994
40. 40 Raisz LG, Fall PM: Biphasic effects of prostaglandin E 2 on bone formation in cultured fetal rat calvariae: interaction with cortisol. Endocrinology 126: 1654–1659, 1990
41. 41 Saad B, Matter S, Ciardelli G, Uhlschmid GK, Welti M, Neuenschwander P, Suter UW: Interactions of osteoblasts and macrophages with biodegradable and highly porous polyesterurethane foam and its degradation products. J Biomed Mater Res 32: 355–366, 1996
42. 42 Santavirta S, Hoikka V, Eskola A, Konttinen YT, Paavilainen T, Talloth K: Aggressive granulomatous lesions in cementless total hip arthroplasty. J Bone Joint Surg [Br] 72: 980–984, 1990
43. 43 Schmalzried TP, Jasty M, Harris WH: Periprosthetic bone loss in total hip arthroplasty: polyethylene wear debris and the concept of the effective joint space. J Bone Joint Surg [Am] 74: 849–863, 1992
44. 44 Schwartz Z, Knight G, Swain LD, Boyan BD: Localization of vitamin D 3 ‐responsive alkaline phosphatase in cultured chondrocytes. J Biol Chem 263: 6023–6026, 1988
45. 45 Schwartz Z, Dennis R, Bonewald L, Swain L, Gomez R, Boyan BD: Differential regulation of prostaglandin E 2 synthesis and phospholipase A 2 activity by 1,25‐(OH) 2 D 3 in three osteoblast‐like cell lines (MC‐3T3‐E1, ROS 17/2.8, and MG‐63). Bone 13: 51–58, 1992
46. 46 Schwartz Z, Swain LD, Marshall T, Sela J, Gross U, Amir D, Mueller‐Mai C, Boyan BD: Modulation of matrix vesicle enzyme activity and phosphatidylserine content by ceramic implant materials during endosteal bone healing. Calcif Tissue Int 51: 429–437, 1992
47. 47 Schwartz Z, Dean DD, Walton JK, Brooks BP, Boyan BD: Treatment of resting zone chondrocytes with 24,25‐dihydroxyvitamin D 3 [24,25‐(OH) 2 D 3 ] induces differentiation into a 1,25‐(OH) 2 D 3 ‐responsive phenotype characteristic of growth zone chondrocytes. Endocrinology 136: 402–411, 1995
48. 48 Scatt A, Bertram P: Bone marrow cells are targets for the anabolic actions of prostaglandin E 2 on bone: induction of a transition from nonadherent to adherent osteoblast precursors. J Bone Miner Res 10: 474–487, 1995
49. 49 Shanbhag AS, Jacobs JJ, Glant TT, Gilbert JL, Black J, Galante JO: Composition and morphology of wear debris in failed uncemented total hip replacement. J Bone Joint Surg [Br] 76: 60–67, 1994
50. 50 Takahashi T, So S, Ikeuchi T, Takahashi K, Kumegawa M: Collagen phagocytosis by osteoblast‐like cells of mouse calvaria in vitro: an electron microscopic study. J Jpn Assoc Periodontol 26: 710–725, 1984
51. 51 Willert HG, Ludwig J, Semlitsch M: Reaction of bone to methacrylate after hip arthroplasty: a long‐term gross, light microscopic, and scanning electron microscopic study. J Bone Joint Surg [Am] 56: 1368–1382, 1974
52. 52 Willert HG, Bertram H, Buchhorn GH: Osteolysis in alloarthroplasty of the hip: the role of ultra‐high molecular weight polyethylene wear particles. Clin Orthop 258: 95–107, 1990
53. 53 Yao J, Cs‐Szabo G, Jacobs JJ, Kuettner KE, Glant TT: Suppression of osteoblast function by titanium particles. J Bone Joint Surg [Am] 79: 107–112, 1997